Related Experiment Video
Updated: Jun 24, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
[Tolerance of two lipid emulsions used in parenterally-fed premature infants - a comparative study]
Agnieszka Gawecka1, Maria K Kornacka, Barbara Łuckiewicz
1Oddział Anestezjologii, Intensywnej Terapii i Opieki Pooperacyjnej SPDSK ul. Marszałkowska 24, 00-576 Warszawa, Poland. maat@maat.pl
Insights
Parenteral nutrition with olive oil or soybean oil lipid emulsions is well tolerated in premature infants. Both effectively maintain normal lipid levels without increasing bilirubin or phototherapy needs.
Area of Science:
- Neonatalogy
- Nutritional Science
- Biochemistry
Background:
- Parenteral nutrition (PN) is crucial for premature infants unable to tolerate enteral feeding.
- Lipid emulsions are a key component of PN for neonates.
- This study compares olive oil-based vs. soybean oil-based lipid emulsions in premature infants.
Purpose of the Study:
- To compare the effects of olive oil-based (ClinOleic) and soybean oil-based (Ivelip) lipid emulsions on plasma lipid concentrations.
- To evaluate the impact of these emulsions on hyperbilirubinemia, assessed by plasma bilirubin levels and phototherapy duration.
- To determine the safety and efficacy of different lipid emulsions in neonatal PN.
Main Methods:
- A double-blind, randomized study involving 44 premature infants (<32 weeks gestation, <1500g birth weight).
- Infants received either olive oil-based or soybean oil-based lipid emulsions within 48 hours of birth.
- Plasma lipid and bilirubin levels were measured on the 7th day of life.
Main Results:
- Both lipid emulsions were well tolerated and maintained normal plasma lipid concentrations.
- The olive oil group showed significantly higher plasma cholesterol and LDL concentrations compared to the soybean oil group.
- No significant differences were observed in plasma bilirubin levels or phototherapy times between the two groups.
Conclusions:
- Both olive oil-based and soybean oil-based lipid emulsions are safe and effective for parenteral nutrition in premature infants.
- These emulsions maintain normal plasma lipid concentrations without adversely affecting bilirubin levels.
- The choice between olive oil and soybean oil emulsions may warrant consideration regarding specific lipid profiles in neonates.
Introduction:
Parenteral nutrition is essential for premature infants during their first days of extrauterine life, when enteral feeding is not tolerated. Lipid emulsions are an integral part of parenteral nutrition. The aim of the study was to compare the effects of two lipid emulsions, based on olive-oil and soybean oil, used in parenteral nutrition of premature infants on: plasma lipid concentrations and hyperbilirubinemia based on plasma bilirubin levels and phototherapy times.
Material And Methods:
Forty-four premature infants aged less than 32 weeks of gestation and with birth weight below 1500 g were randomized within first 48 hours of life, to receive in double-blind manner olive oil based (ClinOleic) or soybean oil based (Ivelip) emulsions. Plasma lipid concentration and bilirubin level were determined at 7(th) day of life.
Results:
Thirty-eight infants completed the study, 18 in the olive oil group (27+/-2 GW, 936+/-218 g) and 20 in the soybean oil group (27+/-2 GW, 924+/-221 g). Both lipid emulsions were well tolerated and plasma lipid concentration were within a normal range, however in olive-oil group plasma cholesterol concentration (159+/-19.89 mg% vs. 128+/-8.85 mg%, p<0.0126) and plasma LDL concentration (103.36+/-8.85 mg% vs. 78.87+/-7.59 mg%, p<0.0342) were significantly higher. Plasma bilirubin levels and phototherapy times did not differ among the groups.
Conclusions:
Both lipid emulsions were well tolerated, maintained normal plasma lipid concentration and did not increase plasma bilirubin level.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Bioavailability Enhancement: Drug Permeability Enhancement
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Membrane Fluidity

